乳腺癌患者的卵巢组织冷冻：半杯空还是半杯满？

IF 3.7 2区医学 Q1 OBSTETRICS & GYNECOLOGY

Reproductive biomedicine online Pub Date : 2024-09-06 DOI:10.1016/j.rbmo.2024.104442

Claus Y. Andersen , Jacques Donnez , Erik Ernst , Debbie Gook , Antonio Pellicer , Michael Von Wolff , Nao Suzuki , Christophe Roux , Marie-Madeleine Dolmans

{"title":"乳腺癌患者的卵巢组织冷冻：半杯空还是半杯满？","authors":"Claus Y. Andersen , Jacques Donnez , Erik Ernst , Debbie Gook , Antonio Pellicer , Michael Von Wolff , Nao Suzuki , Christophe Roux , Marie-Madeleine Dolmans","doi":"10.1016/j.rbmo.2024.104442","DOIUrl":null,"url":null,"abstract":"<div><div>This is a commentary to a paper recently published in <em>RBMOnline</em> by Macklon and De Vos, in which they argue for a discontinuation of ovarian tissue freezing for fertility preservation in women with breast cancer. Instead, they suggest the use of oocyte vitrification following ovarian stimulation as the preferred method of fertility preservation. This commentary presents nine separate arguments that should be considered in the context of ovarian tissue freezing and fertility preservation in girls and women. Collectively, the authors support ovarian tissue freezing going forward and suggest continuing this procedure for fertility preservation in women with breast cancer. Ovarian tissue freezing represents several advantages for patients and provides them with more options following treatment compared with oocyte vitrification.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"50 1","pages":"Article 104442"},"PeriodicalIF":3.7000,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ovarian tissue cryopreservation in breast cancer patients: glass half empty or glass half full?\",\"authors\":\"Claus Y. Andersen , Jacques Donnez , Erik Ernst , Debbie Gook , Antonio Pellicer , Michael Von Wolff , Nao Suzuki , Christophe Roux , Marie-Madeleine Dolmans\",\"doi\":\"10.1016/j.rbmo.2024.104442\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>This is a commentary to a paper recently published in <em>RBMOnline</em> by Macklon and De Vos, in which they argue for a discontinuation of ovarian tissue freezing for fertility preservation in women with breast cancer. Instead, they suggest the use of oocyte vitrification following ovarian stimulation as the preferred method of fertility preservation. This commentary presents nine separate arguments that should be considered in the context of ovarian tissue freezing and fertility preservation in girls and women. Collectively, the authors support ovarian tissue freezing going forward and suggest continuing this procedure for fertility preservation in women with breast cancer. Ovarian tissue freezing represents several advantages for patients and provides them with more options following treatment compared with oocyte vitrification.</div></div>\",\"PeriodicalId\":21134,\"journal\":{\"name\":\"Reproductive biomedicine online\",\"volume\":\"50 1\",\"pages\":\"Article 104442\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2024-09-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reproductive biomedicine online\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S147264832400631X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive biomedicine online","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S147264832400631X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

本文是对 Macklon 和 De Vos 最近发表在《RBMOnline》上的一篇论文的评论，他们在文中主张停止将卵巢组织冷冻用于乳腺癌妇女的生育力保存。相反，他们建议将卵巢刺激后的卵母细胞玻璃化作为生育力保存的首选方法。本评论提出了九个不同的论点，这些论点应在女孩和妇女卵巢组织冷冻和生育力保存的背景下加以考虑。总之，作者支持继续进行卵巢组织冷冻，并建议乳腺癌妇女继续采用这种方法保留生育力。与卵母细胞玻璃化相比，卵巢组织冷冻为患者带来了多项优势，并为她们在治疗后提供了更多选择。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Ovarian tissue cryopreservation in breast cancer patients: glass half empty or glass half full?

This is a commentary to a paper recently published in RBMOnline by Macklon and De Vos, in which they argue for a discontinuation of ovarian tissue freezing for fertility preservation in women with breast cancer. Instead, they suggest the use of oocyte vitrification following ovarian stimulation as the preferred method of fertility preservation. This commentary presents nine separate arguments that should be considered in the context of ovarian tissue freezing and fertility preservation in girls and women. Collectively, the authors support ovarian tissue freezing going forward and suggest continuing this procedure for fertility preservation in women with breast cancer. Ovarian tissue freezing represents several advantages for patients and provides them with more options following treatment compared with oocyte vitrification.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Reproductive biomedicine online 医学-妇产科学

CiteScore

7.20

自引率

7.50%

发文量

391

审稿时长

50 days

期刊介绍： Reproductive BioMedicine Online covers the formation, growth and differentiation of the human embryo. It is intended to bring to public attention new research on biological and clinical research on human reproduction and the human embryo including relevant studies on animals. It is published by a group of scientists and clinicians working in these fields of study. Its audience comprises researchers, clinicians, practitioners, academics and patients. Context: The period of human embryonic growth covered is between the formation of the primordial germ cells in the fetus until mid-pregnancy. High quality research on lower animals is included if it helps to clarify the human situation. Studies progressing to birth and later are published if they have a direct bearing on events in the earlier stages of pregnancy.